In a series of tweets, the president addressed an unusual controversy stemming from a speech Thursday that New York Fed President John Williams delivered.Marketsread more
Companies aren't waiting for the U.S.-China trade war to be resolved, says the head of the world's biggest money manager.Investingread more
Earlier, Williams said in a speech that "it's better to take preventative measures than to wait for disaster to unfold."The Fedread more
The University of Michigan's preliminary print on its consumer sentiment index ticked up to 98.4, from 98.2 in June. Economists polled by Refinitiv expected the preliminary...Economyread more
The mega-cap tech stocks that have led much of the record-long bull run have started to lose steam, but investors are still giving them the benefit of the doubt.Marketsread more
Houston, we have liftoff. Fifty years ago, man landed on the moon and McDonald's and a handful of other stocks took off into the stratosphere. Two of them have more fuel in...Trading Nationread more
Amazon's PillPack was informed this week that it will soon be cut off from patient medication data, according to people familiar with the matter.Technologyread more
An Israeli cybersecurity company has reportedly developed spyware that can scrape data from the servers of Apple, Google, Facebook, Amazon and Microsoft products.Technologyread more
House Speaker Nancy Pelosi is rejecting the White House's most recent debt ceiling proposal, Bloomberg reports.Marketsread more
The country's Revolutionary Guards say they will soon releasePoliticsread more
The U.S. stock market should move higher from near-record current levels, says the co-founder of the world's largest money manager.Marketsread more
Shares of Teva slipped more than 6 percent after the company announced that its CEO will step down and amid reports of a bribery investigation.
The largest generics pharmaceuticals company released a statement Monday that its CEO, ErezVigodman, would resign effective immediately.
"I believe that now is the right time for me to step down," Vigodman said. "It has been a privilege to lead Teva, and I am proud of all we have accomplished. I am confident that the company's future is bright."
Teva's search for its fifth CEO in 15 years comes after a series of missteps, including a string of costly acquisitions and delayed drug launches, that have led to the pharmaceutical company's shares tanking.
In addition to the CEO news, Israeli newspaper HAARETZ reported earlier Tuesday that the Israeli Police are investigating reported bribery in countries such as Mexico, Russia and Ukraine. Israel's biggest company allegedly paid bribes into the hundreds of millions and falsified documents in order to hide them.
CNBC has reached out to Teva for comments.
Teva faced a similar bribery investigation in 2016 and paid $519 million in the U.S. to settle violations of the Foreign Corrupt Practices Act related to the three countries in the Israeli investigation.
The company is reported to release its fourth quarter earnings on Monday, February 13. Teva shares closed Tuesday at $32.19 a share.
— Reuters contributed to this report